CD4 and HIV infectious disease: In persons with HIV infection with a prior diagnosis of AIDS who were virologically suppressed and had CD4 counts of 100–500 per μL, there were no serious safety concerns and the vaccine appeared efficacious based on immunogenicity at standard dosing (27).